Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
Impact of Antiepileptic Medications and Sex Hormones on Maternal and Child Outcomes in Epilepsy
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
Faster Initiation of Diazepam Nasal Spray Associated With More Rapid Seizure Termination
Episode 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia
Analysis of Low-sodium Oxybate Proposes Minimal Clinically Important Difference in Visual Analog Scale for Sleep Inertia
Concomitant Atogepant and Ubrogepant for Acute and Preventive Migraine Demonstrates Safety